Showing results (1-10 of 107) with videos related to
Sort By:
Pageof 11
Methods in Molecular Biology (Clifton, N.J.)|July 29, 2011
In vitro and in vivo silencing of the androgen receptorHelen Cheng, Eric Leblanc, Paul S RennieInternational Journal of Molecular Sciences|January 2, 2019
Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery ApproachesLavinia A Carabet, Paul S Rennie, Artem CherkasovBioengineered Bugs|February 18, 2011
Bioengineered viral vectors for targeting and killing prostate cancer cellsKai-xin Zhang, William Jia, Paul S RennieInternational Journal of Molecular Sciences|June 18, 2013
Targeting alternative sites on the androgen receptor to treat castration-resistant prostate cancerNada Lallous, Kush Dalal, Artem Cherkasov, et al.Nature Reviews. Urology|May 25, 2016
Oncolytic virotherapy for urological cancersZahid Delwar, Kaixin Zhang, Paul S Rennie, et al.International Journal of Molecular Sciences|June 18, 2020
Computer-Aided Ligand Discovery for Estrogen Receptor AlphaDivya Bafna, Fuqiang Ban, Paul S Rennie, et al.Cancer Letters|November 8, 2011
Histone H2A.Z prepares the prostate specific antigen (PSA) gene for androgen receptor-mediated transcription and is upregulated in a model of prostate cancer progressionDeanna Dryhurst, Bethany McMullen, Ladan Fazli, et al.Current Pharmaceutical Biotechnology|July 12, 2011
Targeted oncolytic herpes simplex viruses for aggressive cancersJennifer Wong, Cleo Lee, Kevin Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cellsCleo Y F Lee, Paul S Rennie, William W G JiaThe Prostate|February 17, 2018
A TRAMP-derived orthotopic prostate syngeneic (TOPS) cancer model for investigating anti-tumor treatmentsJustin Lardizabal, Jun Ding, Zahid Delwar, et al.Pageof 11